Keliximab

Recombinant monoclonal antibody to CD4. Keliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.

Target

CD4

Type

IgG1 - lambda

Immunogen

Recombinant fragment (Human) corresponding to the external domain.

Species Reactivity

Human

Expression Host

CHO

Applications

Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.